To our knowledge, this is the first study in human leiomyoma research focusing on determining the profile of E2-mediated IGF-IR/MAPK-related genes and exploring the genomic and nongenomic interactions of ERα/IGF-IR/MAPKp44/42 pathways. This evidence concerns the gene IGF1R and leiomyoma.